FDA review spotlights heart risk of diabetes pill
A review by federal health scientists reinforces potential ties between the diabetes pill Avandia and heart attack and death, opening the door for government action, including a possible withdrawal of the once blockbuster drug.
Blog Content
No comments:
Post a Comment